Latest information on
Skip to Content
Skip to Local Navigation
Skip to Global Navigation
Explore Stanford Medicine
Find a doctor
Pediatrician or pediatric specialist
Clinics & Services
Basic science departments
Clinical science departments
See full directory
Clinical research fellows
Continuing Medical Education
Residencies & fellowships
High School & Undergraduate Programs
Basic science departments
Clinical science departments
Support teaching, research, and patient care.
Ways to give
Why giving matters
Make a gift online
Maps & directions
How you can help
Submit Search Query
Professor of Surgery (Vascular Surgery)
Professor - University Medical Line,
Surgery - Vascular Surgery
Stanford Health Care
300 Pasteur Dr Rm A32
Stanford CA 94305
Tel: (650) 725-5227
Fax: (650) 498-6044
10 Results / Page
Profiles With Related Publications
Euan A. Ashley
Associate Dean, School of Medicine, Roger W. and Joelle G. Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Cardiology, Inherited cardiovascular disease, Hypertrophic Cardiomyopathy, Cardiomyopathy, Dilated, Heart Failure, Arrhythmogenic Right Ventricular Dysplasia, Sports Cardiology, Left ventricular non-compaction cardiomyopathy, Genomic medicine, Undiagnosed disease
The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Pediatric Cardiology, Pediatric Heart Transplantation, Pediatric Heart Failure
1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder.
Ronald L. Dalman MD
Dr. Walter C. Chidester Professor
Vascular Surgery, Aortic Aneurysm, Aortic Diseases, Limb Salvage, Intermittent Claudication, Diabetic Foot, Cerebrovascular Disorders, Carotid Artery Diseases
Vascular biology, arterial remodeling, aneurysm development; innovative treatment strategies for AAA, animal models of arterial disease, arterial remodeling and flow changes in spinal cord injury, genetic regulation of arterial aneurysm formation
Victor Froelicher, MD
Professor of Medicine (Cardiovascular) at the Palo Alto Veterans Affairs Health Care System, Emeritus
Sports Cardiology, Cardiovascular Disease, Wearable ECG devices, Atrial Fibrillation and Exercise, Pre-participation Evaluation
Screening of athletes for sudden cardiac death, Computerized ECG and clinical data management; exercise Physiology including expired gas analysis; the effect of chronic and acute exercise on the heart; digital recording of biological signals; diagnostic use of exercise testing; development of Expert Medical System software and educational tools.
E. John Harris Jr.
Professor of Surgery (Vascular)
I am interested in thrombosis and the role of thrombin and its receptor in venous wall remodeling following venous thrombosis. I am also interested in vascular hemodynamics and the use of ultrasound, MRI and computational modeling in evaluating arterial flow in exercise conditions.
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
Echocardiography, Cardiovascular Disease
My research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).
Mark Hlatky, MD
Professor of Health Policy (Health Services Research), of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Cardiovascular Disease, Cardiovascular Medicine
My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.
Ngan F. Huang
Assistant Professor of Cardiothoracic Surgery (Cardiothoracic Surgery Research) and, by courtesy, of Chemical Engineering
Dr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
Instructor, Medicine - Cardiovascular Medicine
Cardiovascular Disease, Heart Failure, Heart Transplantation, Mechanical Circulatory Support, Left Ventricular Assist Device, Inherited Cardiomyopathy, Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy, Nonischemic cardiomyopathy, Cirrhotic Cardiomyopathy, Iron overload cardiomyopathy
David J. Maron
C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Cardiovascular Disease, Coronary Artery Disease, Angina, High Cholesterol, Familial Hypercholesterolemia, Coronary Artery Calcification, Primary Prevention, Secondary Prevention, Chest Pain
Dr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.
Michael V. McConnell, MD, MSEE
Clinical Professor, Medicine - Cardiovascular Medicine
Coronary Artery Disease, Preventive Cardiology, Cardiovascular Imaging, Mobile Health, Cardiovascular Disease
My imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health to enhance heart-healthy activities in patients and populations.
Publication Topics For This Person
Aged, 80 and over
Aortic Aneurysm, Abdominal
Disease Models, Animal
Gene Expression Regulation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intercellular Signaling Peptides and Proteins
Mice, Inbred C57BL
Muscle, Smooth, Vascular
Peripheral Arterial Disease
Proportional Hazards Models